< Back to latest news & events

Event

G1 19 hearing at the EPO

July 2020

Event date: 15th July 2020

Follow this page for the updates from G1 19 hearing at the EPO in Munich on 15th July 2020. HGF Partners Dr Chris Benson and Bernhard Ganahl will be reporting all the key moments throughout the day and will provide a round up after the hearing both in English and German.

Summary of the case after the EPO hearing on 15th July

Click here to read the summary in English

Klicken Sie hier, um die Zusammenfassung auf Deutsch zu lesen

Social media updates

Click here for updates on LinkedIn

Click here for updates on Twitter

Overview of the case

Click here to read the overview in English

Attendees

Christopher
Benson

Bernhard
Ganahl

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates